How Clinical Trials are designed and why are there more IgAN clinical trials now?
Alex Mercer is an independent consultant specializing in drug development in rare renal diseases, he supports a number of companies with their IgA nephropathy programs. Alex presents the process of developing a clinical trial to test a new treatment in a clear and user-friendly manner.
